The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
The U.S. Supreme Court unanimously decided Monday to restore former president Donald Trump to 2024 presidential primary ballots. The court Monday rejected state attempts to hold the Republican former president accountable for the Capitol riot.
Voyager Ventures founding partners Sarah Sclarsic and Sierra Peterson discuss how they choose products and companies to invest in, and why there’s such high demand for sustainable tech.
